GENEVA, Aug. 7 -- F. HOFFMANN-LA ROCHE AG filed a patent application (EP2026/051945) for “A GLP-1 RECEPTOR MODULATOR FOR USE IN THE TREATMENT OF METABOLIC DISEASES, INCLUDING DIABETES”. With publication no. WO/2026/162461, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/506
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....